China, India, US and Japan Drugs for Treatment of Age-Related Macular Degeneration Research Report to 2020: MarketResearchReports.Biz
The global Drugs for Treatment of Age-related Macular Degeneration market was valued at USD 64.83 Billion in 2015, which sales in US at USD 36.8 billion, and is projected to reach USD 90 Billion by 2021, at a CAGR of 6.78% between 2016 and 2021. Aging population leads to increase the prevalence of AMD, polypharmacy rates rise, the expected drugs enter the market which is studying, and the market quickly absorb those drugs.
View full press release